Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRML | KALV | HROW | ||
| Company | Tourmaline Bio Inc | Kalvista Pharmaceuticals Inc | Harrow Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.98 | 26.78 | 33.39 | ||
| High | 48.00 | 26.80 | 33.39 | ||
| Low | 47.98 | 26.77 | 32.19 | ||
| Latest | 47.98 | 26.79 | 33.00 | ||
| Change | unch | +0.02 | +0.04 | ||
| % Change | unch | +0.07% | +0.12% | ||
| Volume | 783,700 | 1,565,700 | 681,700 | ||
| 20-Day Average Volume | 653,225 | 7,465,250 | 1,007,955 | ||
| Previous Close | 47.98 | 26.77 | 32.96 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.90 | 25.98 | 35.96 | ||
| 20-Day Raw Stochastic | 92.00% | 99.24% | 33.70% | ||
| 20-Day Relative Strength | 88.61 | 71.72 | 41.60 | ||
| Weighted Alpha | +50.87 | +109.31 | +26.43 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 10/20/25 | +0.22% since 05/15/26 | +5.74% since 05/15/26 | ||
| Low | 47.90 on 10/21/25 | 26.71 on 05/19/26 | 30.02 on 05/21/26 | ||
| High | 48.00 on 10/27/25 | 26.83 on 05/20/26 | 33.39 on 05/22/26 | ||
| 1-Month | |||||
| %Chg | +0.50% since 09/26/25 | +36.96% since 04/22/26 | -15.69% since 04/22/26 | ||
| Low | 47.75 on 09/30/25 | 18.66 on 04/24/26 | 28.54 on 05/13/26 | ||
| High | 48.27 on 09/29/25 | 26.85 on 05/13/26 | 41.78 on 04/27/26 | ||
| 3-Month | |||||
| %Chg | +142.69% since 07/25/25 | +69.24% since 02/20/26 | -36.54% since 02/20/26 | ||
| Low | 19.75 on 08/08/25 | 15.09 on 03/19/26 | 28.54 on 05/13/26 | ||
| High | 48.27 on 09/29/25 | 26.85 on 05/13/26 | 54.49 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +184.07% since 04/25/25 | +104.50% since 11/21/25 | -15.19% since 11/21/25 | ||
| Low | 13.27 on 05/20/25 | 13.06 on 11/24/25 | 28.54 on 05/13/26 | ||
| High | 48.27 on 09/29/25 | 26.85 on 05/13/26 | 54.85 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,232,702 | 1,426,326 | 1,230,075 | ||
| Shares Outstanding, K | 25,692 | 53,241 | 37,275 | ||
| Annual Sales | 0 | 49,080,000 | 272,300,000 | ||
| Annual Net Income | -73,210,000 | -109,520,000 | -5,140,000 | ||
| Last Quarter Sales | 0 | 40,860,000 | 44,200,000 | ||
| Last Quarter Net Income | -23,090,000 | -23,490,000 | -27,600,000 | ||
| 60-Month Beta | 2.27 | -0.12 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.90 on 08/13/25 | -0.43 on 05/14/26 | -0.63 on 05/11/26 | ||
| Earnings Date | 11/06/25 | 03/24/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 164.80 | ||